We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAS
851
DELISTED
AGL Resources Inc
GAS
$151K 0.01%
+2,295
New +$151K
AZN icon
852
AstraZeneca
AZN
$244B
$150K 0.01%
2,491
+2,375
+2,047% +$138K
OMCL icon
853
Omnicell
OMCL
$1.72B
$150K 0.01%
4,374
+3,754
+605% +$117K
SBRA icon
854
Sabra Healthcare REIT
SBRA
$5.15B
$150K 0.01%
7,277
+6,577
+940% +$137K
STZ icon
855
Constellation Brands
STZ
$23.3B
$150K 0.01%
909
-1,819
-67% -$285K
ABM icon
856
ABM Industries
ABM
$2.82B
$149K 0.01%
4,082
+3,982
+3,982% +$134K
FNB icon
857
FNB Corp
FNB
$6.88B
$149K 0.01%
11,844
+11,244
+1,874% +$146K
KRNY icon
858
Kearny Financial
KRNY
$604M
$149K 0.01%
+11,880
New +$152K
PLD icon
859
Prologis
PLD
$134B
$149K 0.01%
+3,037
New +$143K
SITC icon
860
SITE Centers
SITC
$158M
$149K 0.01%
6,376
+6,143
+2,636% +$139K
TUP
861
DELISTED
Tupperware Brands Corporation
TUP
$148K 0.01%
2,630
+1,500
+133% +$85.6K
CORE
862
DELISTED
Core Mark Holding Co., Inc.
CORE
$148K 0.01%
3,148
+3,138
+31,380% +$133K
TLN
863
DELISTED
Talen Energy Corporation
TLN
$148K 0.01%
10,937
+10,627
+3,428% +$130K
ISRL
864
DELISTED
Isramco Inc
ISRL
$148K 0.01%
1,804
-186
-9% -$16.4K
DVA icon
865
DaVita
DVA
$11.4B
$147K 0.01%
+1,904
New +$144K
TMP icon
866
Tompkins Financial
TMP
$1.45B
$147K 0.01%
+2,252
New +$148K
ZION icon
867
Zions Bancorporation
ZION
$10.5B
$147K 0.01%
5,833
-3,813
-40% -$101K
DBD
868
DELISTED
Diebold Nixdorf Incorporated
DBD
$147K 0.01%
5,926
+5,678
+2,290% +$146K
DPLO
869
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$147K 0.01%
4,201
+4,168
+12,630% +$131K
MBLY
870
DELISTED
Mobileye N.V.
MBLY
$147K 0.01%
3,187
+3,087
+3,087% +$118K
NSR
871
DELISTED
Neustar Inc
NSR
$147K 0.01%
6,283
-1,045
-14% -$24.8K
BAP icon
872
Credicorp
BAP
$29.8B
$146K 0.01%
+947
New +$136K
CCK icon
873
Crown Holdings
CCK
$12.9B
$146K 0.01%
+2,876
New +$150K
SSP icon
874
E.W. Scripps
SSP
$310M
$146K 0.01%
9,217
+9,138
+11,567% +$146K
POLY
875
DELISTED
Plantronics, Inc.
POLY
$146K 0.01%
3,327
+3,127
+1,564% +$130K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.